Brain Disorder Genetic Kit
Cannalogix Foundation is proud to bring to its members (new and old) the Brain Disorder Genetic Kit. The Brain Disorder Genetic Kit uses DNA to look at several factors to determine a person’s predisposition to brain disorders. We are proud to be a part of this research and will be updating you more as technology advances.
For Patients –
Assess your and your family’s risk for neurodegenerative disorders using an Brain Disorder Genetic kit.
Neurodegenerative disorders are debilitating and incurable diseases where there is a progressive loss in neuronal function, leading to dementia and eventually death.
‘s kit is designed to perform a risk assessment for you and your family by looking at mutations in your genes which have been associated with Parkinson’s, Alzheimer’s, Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease.
Our standard neurodegenerative risk assessment kit comes as a standard assessment for Parkinson’s, Alzheimer’s and Amyotrophic Lateral Sclerosis, with an option to add on Huntington’s Disease.
Parkinson’s disease affects more than 1 million people in the US and an estimated 10 million people worldwide are living with Parkinson’s.
Genetics plays a strong role in Parkinson’s development with around 10% of the cases having an underlying genetic component.
The genetics of Parkinson’s can be causal where a presence of certain genetic mutation can cause Parkinson’s or it can be secondary where presence of certain genetic mutations can severely increase your risk for developing Parkinson’s disease.
The genes associated with Parkinson’s include LRRK2, PARK2, PARK7, PINK1, and SNCA. ‘s kit is designed to assess all of these genes to identify mutations known to increase risk and assess your risk for Parkinson’s disease.
In the US alone, more than 5 million people are living with Alzheimer’s disease and worldwide this number is estimated to be closer to 50 million.
Early-onset Alzheimer’s is a genetic disease and presence of a single dominant mutation can cause the disease. There are three associated genes and these include APP, Presenelin 1 and Presenelin 2. Mutations in these genes virtually guarantees Alzheimer’s development in an individual. Apolipoprotein E (ApoE) gene has been identified as a risk factor for late onset Alzheimer’s.
‘s kits have been designed to perform risk assessment for both early as well as late onset Alzheimer’s disease by analyzing mutations in these genes to assess your and your family’s disease risk.
Amyotrophic Lateral Sclerosis (ALS) – Lou Gehrig’s disease
ALS is a neurodegenerative disease where neurons break down and undergo death leading to significant loss in physical function, eventually impacting the muscles needed to move, speak, eat and breathe.
Approximately 5600 patients are diagnosed every year with ALS in the US and on average 2.2 people out of 100,000 die every year because of ALS. Upto 10% of ALS patients have a genetic predisposition with mutations in SOD1 gene associated with vast numbers of ALS patients with underlying genetic predisposition.
‘s kits have been designed to assess your and your family’s risk for ALS by looking at mutations in SOD1 gene.